COVID-19, Obesity and Lifestyle in Children - Role of Professionals (COLC-Pro)

In this study it is researched how preventive and curative healthcare for children with overweight and obesity was conducted during the Covid-19 pandemic, which barriers were noticed by professionals, and how new methods (such as e-health and telemonitorning) for coaching, communication and healthcare were used and experienced.

Study Overview

• Status: Recruiting
• Conditions: COVID-19; Childhood Obesity; COVID-19 Pandemic; Overweight, Childhood
• Intervention / Treatment: Other: Covid-19 pandemic

• Study Type: Observational
• Enrollment (Anticipated): 385

Contacts and Locations

• Study Contact: Name: Anita CE Vreugdenhil, Prof; Phone Number: 0031433875284; Email: a.vreugdenhil@mumc.nl
• Study Contact Backup: Name: Lisanne Arayess, MD; Email: lisanne.arayess@mumc.nl

Study Locations

• Netherlands
  • Limburg
    • Maastricht, Limburg, Netherlands, 6229 ER
      • Recruiting
      • Maastricht University Medical Center
      • Contact: A.C.E. Vreugdenh

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

Professionals working with children with overweight and/or obesity.

Description

Inclusion Criteria:

• Worked during the Covid-19 pandemic
• Works with children with overweight and / or obesity
• Works in The Netherlands

Exclusion Criteria:

• No knowledge of the Dutch language.

Study Plan

How is the study designed?

Design Details

• Observational Models: Other
• Time Perspectives: Cross-Sectional

Number of groups / cohorts

4

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
Medical doctor	Other: Covid-19 pandemic; All participants worked during the Covid-19 pandemic in the preventive or curative healthcare for children with overweight and obesity. We will ask all professionals about their experiences during and after the pandemic.
Nurses (Pediatric department and youth healthcare)	Other: Covid-19 pandemic; All participants worked during the Covid-19 pandemic in the preventive or curative healthcare for children with overweight and obesity. We will ask all professionals about their experiences during and after the pandemic.
Other professionals in treatment (e.g. dieticians, physiotherapists)	Other: Covid-19 pandemic; All participants worked during the Covid-19 pandemic in the preventive or curative healthcare for children with overweight and obesity. We will ask all professionals about their experiences during and after the pandemic.
Other (such as policy makers)	Other: Covid-19 pandemic; All participants worked during the Covid-19 pandemic in the preventive or curative healthcare for children with overweight and obesity. We will ask all professionals about their experiences during and after the pandemic.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Views and experiences of health care professionals working with children with overweight and obesity during the COVID-19 pandemic	Views and experiences of health care professionals working with children with overweight and obesity during the COVID-19 pandemic measured with a questionnaire using open-end and closed-end (likert-scale) questions.	2 years after the start of the Covid-19 pandemic
User experience	User experience of professionals using ehealth options in healthcare for children with overweight or obesity, measured with a questionnaire using closed end and open end questions.	2 years after the start of the Covid-19 pandemic

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Experiences	In case more in-depth data is needed after the inital questionnaire, semi-structured interviews will be conducted to experiences of health care professionals during the Covid-19 pandemic.	2 years after the start of the Covid-19 pandemic

Collaborators and Investigators

• Sponsor: Maastricht University Medical Center
• Investigators: Principal Investigator: Anita CE Vreugdenhil, Prof, MUMC+, Maastricht University

Study record dates

Study Major Dates

• Study Start (Actual): April 21, 2022
• Primary Completion (Anticipated): August 1, 2022
• Study Completion (Anticipated): April 20, 2023

Study Registration Dates

• First Submitted: April 19, 2022
• First Submitted That Met QC Criteria: April 19, 2022
• First Posted (Actual): April 20, 2022

Study Record Updates

• Last Update Posted (Actual): August 12, 2022
• Last Update Submitted That Met QC Criteria: August 9, 2022
• Last Verified: August 1, 2022

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Virus Diseases; Infections; Respiratory Tract Infections; Respiratory Tract Diseases; Pneumonia, Viral; Pneumonia; Lung Diseases; Overnutrition; Nutrition Disorders; Body Weight; COVID-19; Obesity; Pediatric Obesity; Overweight
• Other Study ID Numbers: 2020-1634

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: Undecided

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No